ALZHEIMER'S DISEASE AND DEMENTIA
IS A WORLDWIDE CHALLENGE
TODAY, NO CURE IS AVAILABLE
ADx NeuroSciences is a R&D company committed to improving the diagnosis of Alzheimer’s disease & dementia. The company identifies and develops novel biomarkers for accurate diagnosis and the effective treatment and follow-up of patients suffering from Alzheimer’s, Parkinson’s and other neurodegenerative diseases.Read More
Development of own proprietary stand-alone biomarkers and in-licensing of newly discovered markers from academic and industrial partners.
Development and co-development of tailor-made new generation companion diagnostics for neurodegenerative disorders.